Latest news with #OPK
Winnipeg Free Press
a day ago
- Climate
- Winnipeg Free Press
Look for the helpers
It's easy these days to get caught in the trap of thinking everything is awful. But I'm here to assure you, folks, there's still plenty of good happening in the world — even if it sometimes gets buried beneath all the doom and gloom. The past few days have been a healthy reminder for me. Let's start with Monday, when I took part in one of my favourite summer events — a charity golf tournament. This one was in support of Manitoba's Cardiac Centre of Excellence at St. Boniface Hospital, which helps tens of thousands of patients every year. Mother Nature (mostly) cooperated, keeping the forecasted rain (mostly) at bay, and by day's end, $100,000 had been raised — money that will do wonders for the community. It was a vivid reminder of the generous spirit of Manitobans, and it definitely warmed my heart as I played on the Free Press team along with president and CEO Mike Power and vice-president of revenue and business development Michele Prysazniuk. Advertisement Why this ad? On Tuesday morning, I joined about 50 volunteers as they hit the streets of Winnipeg to deliver kindness to those who need it most. Led by Mitch Bourbonniere and the incredible folks at Ogijiita Pimatiswin Kinamatwin (OPK), they head out twice a week with much-needed food, water, clothing and personal supplies for dozens of people living on the streets. This was part of a bigger project I've been working on this summer, with the finished product set to appear next month in the newspaper. The outing reminded me of a story Fred Rogers — better known as Mr. Rogers — often told about his mother: 'When I was a boy and I would see scary things in the news, my mother would say to me, 'Look for the helpers. You will always find people who are helping.'' Anyone driving down Main Street that morning would have seen the helpers in spades. It was a poignant, powerful display. And then, earlier today, I found myself back on the golf course — this time to meet a remarkable young man from Minnesota. Charlie Bristow has built a large following through his Instagram account, Charlie's Golfing Club. Charlie lives with advanced scoliosis and is on the autism spectrum, and he's found comfort in the game of golf, travelling across the United States — and now into Canada — to tee it up. A Winnipegger named Eugene Hayduk heard about Charlie's journey and invited him and his father to play here. I was asked to round out their foursome. 'Charlie's story inspired me, as I've worked with a number of youth with autism spectrum disorder,' said Hayduk, a social worker. 'I've also endured several surgeries for my stage-four cancer diagnosis, as has Charlie for his scoliosis. Seeing him swing the club, given his challenges, inspired me — so I've been following his journey closely.' I'm writing a feature story on Charlie and his experience, which you'll find online Friday afternoon and in Saturday's paper. Like Hayduk — and now myself — I hope you, too, will come away inspired. A few programming notes for the coming weeks: Next week, I'll have daily tee-to-green coverage of the Manitoba Open, being held this year at Breezy Bend. Talk about a full-circle moment — the last time the course hosted the tournament was in 1993, when I was an 18-year-old caddying in it. Now, 32 years later, I'll be covering it for the Free Press for the eighth time. Four-time men's amateur champ Braxton Kuntz will start his pro career on his home golf course at the Manitoba Open. (Thomas Friesen / The Brandon Sun files) I had the chance to sneak in a round at Breezy on Tuesday — yes, I've been doing a LOT of 'work-related' golfing this week — and let me just say the PGA Tour Americas pros are in for a treat. The course is in pristine condition. One piece of advice to the field of 156, not that they need any from a duffer like me: stay out of the rough. It's already about four inches long, and by the time the 72-hole event begins next Thursday, it'll be closer to five. It can be a beast to escape. I speak from experience — after hacking my way through it all afternoon, my arms and back are still feeling it. Once a new champion is crowned on Aug. 24, I'll be stepping away from the paper (and this newsletter) for a brief holiday break, returning Sept. 9. When I'm back, I'll be putting the finishing touches on that news project I mentioned earlier before diving head-first into what should be a fascinating season of Winnipeg Jets coverage. This will be my 10th year on the hockey beat, and it all gets rolling Sept. 17 when training camp officially opens. We've got big plans this year — including taking our NHL coverage all the way to Italy, where I'll be in Milan for the Winter Olympics. I can't wait.
Yahoo
01-08-2025
- Business
- Yahoo
Compared to Estimates, OPKO Health (OPK) Q2 Earnings: A Look at Key Metrics
OPKO Health (OPK) reported $156.8 million in revenue for the quarter ended June 2025, representing a year-over-year decline of 13.9%. EPS of -$0.19 for the same period compares to -$0.01 a year ago. The reported revenue represents a surprise of -5.09% over the Zacks Consensus Estimate of $165.22 million. With the consensus EPS estimate being -$0.12, the EPS surprise was -58.33%. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health. Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance. Here is how OPKO Health performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenues- Revenue from transfer of intellectual property and other: $15 million versus the five-analyst average estimate of $20.07 million. The reported number represents a year-over-year change of +22%. Revenues- Revenue from products: $40.7 million versus $40.88 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +0.5% change. Revenues- Revenue from services: $101.1 million versus $104.29 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a -21.9% change. View all Key Company Metrics for OPKO Health here>>> Shares of OPKO Health have remained unchanged over the past month versus the Zacks S&P 500 composite's +2.7% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report OPKO Health, Inc. (OPK) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
Yahoo
15-05-2025
- Business
- Yahoo
OPKO Health to Participate in Two Upcoming Investor Conferences
MIAMI, May 15, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in two investor conferences over the coming weeks. H.C. Wainwright 3rd Annual BioConnect Investor Conference at Nasdaq, May 20 in New York City. Management will hold one-on-one meetings with investors and will participate in a fireside discussion at 9:00 a.m. Eastern time. Jefferies Global Healthcare Conference, June 3-5 at the Marriott Marquis in New York City. Management will hold one-on-one meetings with investors on Wednesday, June 4th and will participate in a fireside discussion on Wednesday, June 4th at 11:05 a.m. Eastern time. The fireside discussions at both conferences will be webcast live and available for replay in the Investors section of OPKO Health's website and accessible by clicking here. About OPKO Health OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit Contacts: Alliance Advisors IR Yvonne Briggs, 310-691-7100 ybriggs@ Voss, 310-691-7100 bvoss@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
San Francisco Chronicle
30-04-2025
- Business
- San Francisco Chronicle
OPKO Health: Q1 Earnings Snapshot
MIAMI (AP) — MIAMI (AP) — Opko Health Inc. (OPK) on Wednesday reported a loss of $67.6 million in its first quarter. On a per-share basis, the Miami-based company said it had a loss of 10 cents. The results did not meet Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 6 cents per share. The holding company with investments in pharmaceutical and diagnostics companies posted revenue of $149.9 million in the period, also falling short of Street forecasts. Six analysts surveyed by Zacks expected $164.5 million.
Yahoo
20-03-2025
- Business
- Yahoo
Chairman & CEO of OPKO Health Phillip Frost Buys More Stock
Investors who take an interest in OPKO Health, Inc. (NASDAQ:OPK) should definitely note that the Chairman & CEO, Phillip Frost, recently paid US$1.74 per share to buy US$348k worth of the stock. Although the purchase is not a big one, by either a percentage standpoint or absolute value, it can be seen as a good sign. Check out our latest analysis for OPKO Health In fact, the recent purchase by Chairman & CEO Phillip Frost was not their only acquisition of OPKO Health shares this year. They previously made an even bigger purchase of US$781k worth of shares at a price of US$1.56 per share. Even though the purchase was made at a significantly lower price than the recent price (US$1.86), we still think insider buying is a positive. While it does suggest insiders consider the stock undervalued at lower prices, this transaction doesn't tell us much about what they think of current prices. Phillip Frost purchased 2.53m shares over the year. The average price per share was US$1.52. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you want to know exactly who sold, for how much, and when, simply click on the graph below! There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of undervalued small cap companies that insiders are buying. For a common shareholder, it is worth checking how many shares are held by company insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. It's great to see that OPKO Health insiders own 52% of the company, worth about US$624m. Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders. It is good to see the recent insider purchase. And the longer term insider transactions also give us confidence. But on the other hand, the company made a loss during the last year, which makes us a little cautious. Once you factor in the high insider ownership, it certainly seems like insiders are positive about OPKO Health. That's what I like to see! In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing OPKO Health. To assist with this, we've discovered 1 warning sign that you should run your eye over to get a better picture of OPKO Health. Of course OPKO Health may not be the best stock to buy. So you may wish to see this free collection of high quality companies. For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
